RxSight

RXST - RxSight • Financials

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

Year
12/2019
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2020
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2021
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2022
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
12/2023
89
-46
-
L
L
160
L
-127
-
-57
-5
62
-62
-1
0
-
-
12/2024
140
-33
-
L
L
281
L
-237
-
-42
-5
123
-47
-5
0
-
-
12/2025
134
-45
-
L
L
276
L
-228
-
-47
-4
2
-51
-2
0
-
-